BioCatch vs Netskope
In-depth comparison — valuation, funding, investors, founders & more
🇮🇱 Israel · Avi Turgeman
Valuation
$1B
Total Funding
$213M
100-500 employees
🇺🇸 United States · Sanjay Beri
Valuation
$7.3B
Total Funding
$1.4B
2500 employees
Analyst Summary
Generated from real data · No AI hallucinations
Both BioCatch and Netskope compete directly in the AI Security space, making this a head-to-head matchup within the same market segment. BioCatch provides behavioural biometrics and fraud prevention AI that analyses how users physically interact with digital devices — mouse movements, typing cadence, touch pressure, and navigation patterns — to authenticate genuine users and detect account takeover, social engineering, and application fraud in real time during banking and financial transactions. Netskope is a cloud-native security platform founded in 2012 that protects organizations against data exfiltration and cyber threats across cloud applications and web services.
Netskope carries a valuation of $7.3B, which is 7.3x higher than BioCatch's $1B. On the funding side, Netskope has raised $1.4B in total — $1.2B more than BioCatch's $213M.
BioCatch has 1 year more market experience, having been founded in 2011 compared to Netskope's 2012 founding. In terms of growth stage, BioCatch is at Series D while Netskope is at Public — a meaningful difference for investors evaluating risk and upside.
BioCatch operates out of 🇮🇱 Israel while Netskope is based in 🇺🇸 United States, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, both companies are closely matched — BioCatch scores 80 and Netskope scores 78.
Metrics Comparison
| Metric | BioCatch | Netskope |
|---|---|---|
💰Valuation | $1B | $7.3BWINS |
📈Total Funding | $213M | $1.4BWINS |
📅Founded | 2011 | 2012WINS |
🚀Stage | Series D | Public |
👥Employees | 100-500 | 2500 |
🌍Country | Israel | United States |
🏷️Category | AI Security | AI Security |
⭐Awaira Score | 80WINS | 78 |
Key Differences
Valuation gap: Netskope is valued 7.3x higher ($7.3B vs $1B)
Funding gap: Netskope has raised $1.2B more ($1.4B vs $213M)
Market experience: BioCatch has 1 year more (founded 2011 vs 2012)
Growth stage: BioCatch is at Series D vs Netskope at Public
Team size: BioCatch has 100-500 employees vs Netskope's 2500
Market base: 🇮🇱 BioCatch (Israel) vs 🇺🇸 Netskope (United States)
Direct competitors: Both operate in the AI Security market segment
Awaira Score: BioCatch scores 80/100 vs Netskope's 78/100
Which Should You Choose?
Use these signals to make the right call
Choose BioCatch if…
Top Pick- ✓Higher Awaira Score — 80/100 vs 78/100
- ✓More market experience — founded in 2011
- ✓Israel-based for regional compliance or proximity
- ✓BioCatch provides behavioural biometrics and fraud prevention AI that analyses how users physically interact with digital devices — mouse movements, typing cadence, touch pressure, and navigation patterns — to authenticate genuine users and detect account takeover, social engineering, and application fraud in real time during banking and financial transactions
Choose Netskope if…
- ✓More established by valuation ($7.3B)
- ✓Stronger investor backing — raised $1.4B
- ✓United States-based for regional compliance or proximity
- ✓Netskope is a cloud-native security platform founded in 2012 that protects organizations against data exfiltration and cyber threats across cloud applications and web services
Funding History
BioCatch raised $213M across 0 rounds. Netskope raised $1.4B across 6 rounds.
BioCatch
No public funding data available.
Netskope
IPO
Sep 2022
Series E
Jan 2021
Series D
Sep 2020
Lead: Sequoia Capital
Series C
Jan 2018
Lead: Sapphire Ventures
Series B
Jan 2015
Lead: Norwest Venture Partners
Series A
Jan 2014
Lead: Accel Partners
Investor Comparison
No shared investors detected between these two companies.
Unique to Netskope